Compugen Valuation

CGEN Stock  USD 1.91  0.07  3.54%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Compugen shows a prevailing Real Value of $2.58 per share. The current price of the firm is $1.91. Our model approximates the value of Compugen from analyzing the firm fundamentals such as Current Valuation of 127.94 M, return on equity of -0.26, and Profit Margin of (0.56) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Compugen's valuation include:
Price Book
2.9088
Enterprise Value
127.9 M
Enterprise Value Ebitda
(12.13)
Price Sales
6.044
Enterprise Value Revenue
4.5383
Undervalued
Today
1.91
Please note that Compugen's price fluctuation is very risky at this time. Calculation of the real value of Compugen is based on 3 months time horizon. Increasing Compugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Compugen is useful when determining the fair value of the Compugen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Compugen. Since Compugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugen Stock. However, Compugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.91 Real  2.58 Target  4.67 Hype  1.88 Naive  1.85
The real value of Compugen Stock, also known as its intrinsic value, is the underlying worth of Compugen Company, which is reflected in its stock price. It is based on Compugen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Compugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Compugen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.58
Real Value
7.40
Upside
Estimating the potential upside or downside of Compugen helps investors to forecast how Compugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugen more accurately as focusing exclusively on Compugen's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.11-0.020.07
Details
Hype
Prediction
LowEstimatedHigh
0.091.886.70
Details
Naive
Forecast
LowNext ValueHigh
0.041.856.66
Details
3 Analysts
Consensus
LowTarget PriceHigh
4.254.675.18
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Compugen's intrinsic value based on its ongoing forecasts of Compugen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Compugen's closest peers. When choosing an evaluation method for Compugen, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Compugen Investments

37.29 Million

Compugen Valuation Trend

Knowing Compugen's actual value is paramount for traders to make sound investment determinations. Compugen's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Compugen's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Compugen's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Compugen Market Cap

Compugen is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 12.32 Billion. Compugen claims roughly 177.27 Million in market capitalization contributing just under 2% to equities under Health Care industry.
Capitalization  Valuation  Total debt  Revenue  Workforce

Compugen Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Compugen's current stock value. Our valuation model uses many indicators to compare Compugen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Compugen competition to find correlations between indicators driving Compugen's intrinsic value. More Info.
Compugen is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . As of the 25th of April 2024, Price To Book Ratio is likely to grow to 3.68. Comparative valuation analysis is a catch-all model that can be used if you cannot value Compugen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Compugen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugen's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Compugen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Compugen and how it compares across the competition.

About Compugen Valuation

The stock valuation mechanism determines the current worth of Compugen on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Compugen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Compugen based exclusively on its fundamental and basic technical indicators. By analyzing Compugen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Compugen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compugen. We calculate exposure to Compugen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Compugen's related companies.
Last ReportedProjected for Next Year
Gross Profit31 M32.5 M
Pretax Profit Margin(0.29)(0.31)
Operating Profit Margin(0.39)(0.41)
Net Loss(0.56)(0.59)
Gross Profit Margin 0.93  0.87 

8 Steps to conduct Compugen's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Compugen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Compugen's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Compugen's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Compugen's revenue streams: Identify Compugen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Compugen's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Compugen's growth potential: Evaluate Compugen's management, business model, and growth potential.
  • Determine Compugen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Compugen's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Compugen Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Compugen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding87.6 M

Compugen Current Valuation Indicators

Valuation refers to the process of determining the present value of Compugen and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Compugen we look at many different elements of the entity such as Compugen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Compugen's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Compugen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Compugen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Compugen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Compugen's worth.
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Note that the Compugen information on this page should be used as a complementary analysis to other Compugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Is Compugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.21)
Revenue Per Share
0.382
Quarterly Revenue Growth
3.461
Return On Assets
(0.08)
Return On Equity
(0.26)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.